Cargando…
Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer
Colorectal cancer is one of the most common malignant tumors and, hence, has become one of the most important public health issues in the world. Treatment with immune checkpoint inhibitors (ICIs) successfully improves the survival rate of patients with melanoma, non‐small‐cell lung cancer, and other...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761449/ https://www.ncbi.nlm.nih.gov/pubmed/34817097 http://dx.doi.org/10.1002/jcla.24141 |